Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Candidemia: full-pipeline trial registry
2 of 9 indexed Candidemia trials are currently recruiting.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 2 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Candidemia: 9 US clinical trials tracked, 2 recruiting.
Candidemia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Astellas Pharma, running 4 of these trials.
Enrollment posture brief
Registry condition candidemia
OPEN 2 | RECR 22% | LATE 4 | EARLY 4 | RANK #1916 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acne (22% recruiting · 27 trials)
Candidemia lists 2 open slots (22% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Candidemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Candidemia is recruiting below its size-band peers.
2 of 9 indexed trials (22.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Candidemia research.
Astellas Pharma accounts for 4 of 9 trials (44.4%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Candidemia enrolment sits around 450 participants.
Median target enrolment is 450 among the 9 trials that report a genuine target (sentinel values excluded). 2 of those (22.2%) plan for fewer than 100 participants.
-
Candidemia research is mostly interventional.
8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Basilea Pharmaceutica
NCT05421858
Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
Radboud University Medical Center
NCT04979052
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Mundipharma Research Limited
NCT04368559
Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)
T2 Biosystems
NCT01525095
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
Astellas Pharma
NCT00105144
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Astellas Pharma
NCT00413218
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
Cidara Therapeutics
NCT02734862
Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Astellas Pharma
NCT00608335
Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Astellas Pharma
NCT00607763
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Candidemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Candidemia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Candidemia page
9 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Candidemia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Astellas Pharma sponsors the most Candidemia trials on record, review their full trial history before evaluating a specific study. See Astellas Pharma's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Candidemia condition card totals 9 registered trials; most-linked intervention Caspofungin; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.